IL-2/IL-15 activate the human clonally restricted KIR3DL1 reverse promoter.

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• Killer cell immunoglobulin-like receptors (KIRs) are crucial for natural killer (NK) cell function, enabling the detection of cells with low major histocompatibility complex class I.
• KIR gene expression is clonally restricted and maintained by promoter demethylation, with antisense transcripts potentially silencing non-expressed alleles.

Purpose of the Study:

• To investigate the role of interleukin (IL)-2 and IL-15 in regulating KIR gene expression in NK cells.
• To elucidate the mechanism by which these cytokines influence KIR3DL1 promoter activity and identify key regulatory factors.

Main Methods:

• Reporter assays to measure KIR3DL1 promoter activity (forward and reverse).
• Analysis of STAT5 activation and binding to the KIR3DL1 promoter using Western blotting and chromatin immunoprecipitation.
• Systematic investigation of regulatory elements within the KIR3DL1 reverse promoter.

Main Results:

• IL-2 and IL-15 significantly stimulated KIR3DL1 reverse promoter activity, but not forward promoter activity.
• Activated STAT5 was essential and sufficient for this stimulation and bound to the KIR3DL1 promoter in relevant NK cell populations.
• The KIR3DL1 reverse promoter exhibited distinct regulatory features compared to the forward promoter, with STAT and YY1 sites playing a significant role.

Conclusions:

• IL-2 and IL-15 promote KIR gene expression initiation through STAT5 activation and binding to the KIR3DL1 reverse promoter.
• Antisense transcripts may play a novel role in initiating KIR gene expression during NK cell development.
• These findings provide new insights into the regulation of KIR expression and NK cell biology.